Phase II study of 131I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.

Autor: Sevrin, François, Kolesnikov‐Gauthier, Hélène, Cougnenc, Olivier, Bogart, Emilie, Schleiermacher, Gudrun, Courbon, Frederic, Gambart, Marion, Giraudet, Anne‐Laure, Corradini, Nadège, Badel, Jean‐Noël, Rault, Erwann, Oudoux, Aurore, Deley, Marie Cécile Le, Valteau‐Couanet, Dominique, Defachelles, Anne‐Sophie
Zdroj: Pediatric Blood & Cancer; Nov2023, Vol. 70 Issue 11, p1-9, 9p
Databáze: Complementary Index
Externí odkaz: